MSH Capital Advisors LLC bought a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 9,998 shares of the company’s stock, valued at approximately $1,285,000.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. Frazier Financial Advisors LLC acquired a new stake in Merck KGaA in the 2nd quarter valued at $25,000. Addison Advisors LLC bought a new stake in Merck KGaA in the second quarter valued at $90,000. Comprehensive Financial Planning Inc. PA acquired a new position in Merck KGaA during the second quarter worth $134,000. Stevens Capital Partners acquired a new position in Merck KGaA during the second quarter worth $220,000. Finally, United Bank bought a new position in shares of Merck KGaA during the second quarter valued at $248,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 4.5%
Shares of OTCMKTS:MKGAF opened at $167.38 on Thursday. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The company’s fifty day moving average is $162.50 and its 200-day moving average is $148.28. The company has a market capitalization of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
